KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Taxes (2016 - 2019)

Historic Change in Taxes for Arbutus Biopharma (ABUS) over the last 9 years, with Q1 2019 value amounting to -$98000.0.

  • Arbutus Biopharma's Change in Taxes fell 500000.0% to -$98000.0 in Q1 2019 from the same period last year, while for Mar 2019 it was -$51000.0, marking a year-over-year decrease of 18947.37%. This contributed to the annual value of $49000.0 for FY2018, which is 5462.96% down from last year.
  • Arbutus Biopharma's Change in Taxes amounted to -$98000.0 in Q1 2019, which was down 500000.0% from $47000.0 recorded in Q4 2018.
  • Arbutus Biopharma's Change in Taxes' 5-year high stood at $241000.0 during Q4 2017, with a 5-year trough of -$294000.0 in Q2 2017.
  • Moreover, its 5-year median value for Change in Taxes was $25000.0 (2015), whereas its average is $23363.6.
  • Its Change in Taxes has fluctuated over the past 5 years, first surged by 6620.69% in 2017, then tumbled by 500000.0% in 2019.
  • Over the past 5 years, Arbutus Biopharma's Change in Taxes (Quarter) stood at $164000.0 in 2015, then dropped by 11.59% to $145000.0 in 2016, then surged by 66.21% to $241000.0 in 2017, then plummeted by 80.5% to $47000.0 in 2018, then plummeted by 308.51% to -$98000.0 in 2019.
  • Its Change in Taxes stands at -$98000.0 for Q1 2019, versus $47000.0 for Q4 2018 and $2000.0 for Q1 2018.